Analyst Ratings for Kinnate Biopharma (KNTE)

KNTE Rating Summary

  |   Expand Research on KNTE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/16/2024 William Blair Tim Lugo Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 2.27
(2.65)		 16.74% Details
9/19/2023 Wedbush David Nierengarten Downgrade Neutral
(Outperform)		 2.00
(14.00)		 1.70
(2.65)		 55.88% Details